Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Neumentum, Inc. logo — company profile

Neumentum, Inc.

Founded 2017 United States Morristown, United States 6 employees Venture round Biotechnology, Health Care +3

General Information

Company Name Neumentum, Inc.
Founded Year 2017
Location United States Morristown, United States
Employees 6
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Neumentum, Inc.. To contact Neumentum, Inc., visit neumentum.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neumentum, Inc. compare?

A PDF of Neumentum, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neumentum, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neumentum, Inc.

Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by developing and commercializing effective and safe, non-opioid options without the risks of abuse, misuse, and diversion seen with opioids, or the opioid-induced side effects, including potentially life-threatening respiratory depression. Neumentum has two lead product candidates being developed to directly help address the opioid crisis. NTM-001, currently in Phase 3, is an IV formulation of Toradol (ketorolac) with Phase I results showing that it may provide consistent, steady blood plasma levels of ketorolac over 24 hours and durable analgesic effect. NTM-001 has the potential to be the first-ever NSAID approved for continuous infusion. NTM-006, a Phase 2 novel oral analgesic with a target indication for acute and chronic pain that has demonstrated meaningful analgesia in a Phase 2a Proof of Concept study, was licensed from Janssen Pharmaceuticals NV and McNeil Consumer Pharmaceuticals Co., both part of the Johnson & Johnson Family of Companies. Neumentum is led by an executive team of biotech and pharmaceutical experts who have extensive experience in pain and neurology, from drug development through commercialization. For more information, visit www.Neumentum.com.

No funding data available for Neumentum, Inc. yet.

Neumentum, Inc. Alternatives & Competitors

View All Alternatives
Neumentum, Inc. vs
MAXONA Pharmaceuticals
MAXONA Pharmaceuticals United States

Maxona pharmaceuticals is committed to leveraging an ex-u

9 employees
Biotechnology, Health Care
Neumentum, Inc. vs
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. United States

Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and comme...

Venture round
2 employees
Biotechnology, Pharmaceutical
Neumentum, Inc. vs
Glycyx
Glycyx United States

Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance immunother...

Series A
3 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Neumentum, Inc.

Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by devel...
Neumentum, Inc. was founded in 2017.
Neumentum, Inc. is headquartered in Morristown, United States.
Neumentum, Inc. operates in Biotechnology, Health Care, Health and Wellness, Life Sciences and Pharmaceutical.
Neumentum, Inc. has approximately 6 employees.
Top alternatives and competitors to Neumentum, Inc. include MAXONA Pharmaceuticals, Semnur Pharmaceuticals, Inc., Glycyx, Charleston Laboratories, Inc., Baudax Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neumentum, Inc. and MAXONA Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neumentum, Inc., https://bouncewatch.com/company/neumentum-inc, updated 17 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout